Terumo : Announces Voting Results for the Election of Directors

Press Release

Terumo Announces Voting Results for the Election of Directors

TOKYO, JAPAN - June 26, 2024 - Terumo Corporation (TSE: 4543) hereby announces the voting results for the election of directors held at the Annual General Meeting of Shareholders today. All eight of the candidates listed on May 14 announcement were elected as directors of Terumo Corporation. Also, Terumo appointed Representative Directors at the subsequent Board of Directors held today.

The three directors serving as Audit and Supervisory Committee members, elected on June 27, 2023, continue to hold office.

1. Directors

(Excluding directors who serve as Audit and Supervisory Committee Members)

Name		New position		Previous position
Toshiaki Takagi		Representative Director and Chairman of the		Same as on the left
	Board
Hikaru Samejima		Representative Director and Chief Executive		Chief Executive Officer
	Officer
Toshihiko Osada		Director and Group Senior Managing Executive		Group Senior Managing
	Officer		Executive Officer
Kazunori Hirose		Director and Group Managing Executive Officer		Same as on the left
Norimasa Kunimoto		Director and Group Managing Executive Officer		Same as on the left
Hidenori Nishi		Independent Director		Same as on the left
Keiya Ozawa		Independent Director		Same as on the left
Mari Kogiso		Independent Director	-
2. Directors who serve as Audit and Supervisory Committee Members
Name		Current position
Takanori Shibazaki		Director (Full-time Audit and Supervisory Committee Member)
Masaichi Nakamura		Independent Director (Audit and Supervisory Committee Member)
Soichiro Uno		Independent Director (Audit and Supervisory Committee Member)

About Terumo

Terumo (TSE:4543) is a global leader in medical technology and has been committed to "Contributing to Society through Healthcare" for 100 years. Based in Tokyo and operating globally, Terumo employs more than 30,000 associates worldwide to provide innovative medical solutions in more than 160 countries and regions. The company started as a Japanese thermometer manufacturer, and has been supporting healthcare ever since. Now, its extensive business portfolio ranges from vascular intervention and cardio-surgical solutions, blood transfusion and cell therapy technology, to medical products essential for daily clinical practice. Terumo will further strive to be of value to patients, medical professionals, and society at large.